(HealthDay)—Adults diagnosed with type 2 diabetes between the ages of 21 and 44 years have higher initial hemoglobin A1c (HbA1c) levels and a lower likelihood of achieving glycemic control within one year of diagnosis versus patients diagnosed in middle age, according to a study recently published in Diabetes Care.
Anjali Gopalan, M.D., from Kaiser Permanente Northern California in Oakland, and colleagues examined data from a large, integrated health care system to identify 32,137 adults (aged 21 to 64 years) with incident diabetes (first HbA1c, ≥6.5 percent). Glycemic control and initial care between adults with younger onset of type 2 diabetes (21 to 44 years) was compared to that of patients with middle-age onset (45 to 64 years).
The researchers found that 26.4 percent had younger-onset and 73.6 percent had middle age-onset type 2 diabetes. Higher initial mean HbA1c values (8.9 percent) were seen among adults with younger onset versus adults with middle-age onset (8.4 percent). Even after adjusting for HbA1c at diagnosis, adults with younger onset had lower odds of achieving an HbA1c middle-age onset, adults with younger onset had lower odds of in-person primary care contact (aOR, 0.82; 95 percent CI, 0.76 to 0.89), but they did not differ in telephone contact (aOR, 1.05; 95 percent CI, 0.99 to 1.10). Odds of starting metformin were higher in adults with younger onset (aOR 1.20; 95 percent CI, 1.12 to 1.29), but they had lower odds of adhering to the medication (aOR, 0.74; 95 percent CI, 0.69 to 0.80).
“Adults with onset of type 2 diabetes at a younger age were less likely to achieve glycemic control at one year following diagnosis, suggesting the need for tailored care approaches to improve outcomes for this high-risk patient population,” the authors write.
High HbA1c after T1DM diagnosis predicts psychiatric comorbidity
Abstract/Full Text (subscription or payment may be required)
Copyright © 2020 HealthDay. All rights reserved.
Younger onset of T2DM tied to poorer initial glycemic control (2020, April 10)
retrieved 10 April 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022